REFERENCES
- Ohlsen RI, Pilowsky LS. The place of partial agonism in psychiatry: recent developments. J Psychopharmacol. 2005;19:408–413.
- Haro JM, Salvador-Carulla L. The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia. CNS Drugs. 2006;20:293–301.
- Kanofsky JD, Woesner ME, Harris AZ, Kelleher JP, Gittens K, Jerschow E. A case of acute renal failure in a patient recently treated with clozapine and a review of previously reported cases. Prim Care Companion CNS Disord. 2011;13:3.
- Schulz SC, Camlin KL, Berry SA, Jesberger JA. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia. Biol Psychiatry. 1999;46:1429–1435.
- Street JS, Clark WS, Gannon KS, Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry. 2000;57:968–976.
- Thase ME, Demyttenaere K, Earley WR, Gustafsson U, Udd M, Eriksson H. Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression. Depress Anxiety. 2012;29:574–586.
- Gulec M, Ozcan H, Oral E, Nephrotoxic effects of chronically administered olanzapine and risperidone in male rats. BCP. 2012;22:139–147.
- Ng B, Postlethwaite A, Rollnik J. Peripheral oedema in patients taking olanzapine. Int Clin Psychopharmacol. 2003;18:57–59.
- Koleva HK, Erickson MA, Vanderlip ER, Tansey J, Mac J, Fiedorowicz JG. 3 case reports of edema associated with quetiapine. Ann Clin Psychiatry. 2009;21:77–80.
- Michel DM, Kelly CJ. Acute interstitial nephritis. J Am Soc Nephrol. 1998;9:506–515.
- Gonzalez E, Gutierrez E, Galeano C, Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int. 2008;73:940–946.